Boston Molecules is a leading custom antibody developer facilitated with cutting edge technologies and innovations. Our B-cell cloning antibody platform is emerging as the world’s best monoclonal antibody development strategies that outperformed traditional hybridoma technologies by more than 10 fold increase of positive colony numbers and superior affinities in selected antibodies. Cohesive with our Bioinformatics scientists and Crystallography scientists, our custom antibody services deliver >90% successful projects by guaranteed antibody development strategies including antigen 3D structure prediction and homologous sequence exclusions. We also offer 60-70 days short turnaround cost-efficient polyclonal antibody services with free epitobe prediction service.​

Our customer antibody production package includes free premium epitope prediction and design, protein/peptide antigen production, guaranteed full 2-month immunization timelines, and delivery of antigen-specific affinity purified antibody with ELISA titer > 1:64,000. Our average success rate for western blotting or ICC/IF application of a given protein is >80% for single peptide antigen immunization, and >95% for double peptide antigen immunization. We also provide application guaranteed packages for our customers. All you need to do is providing target sequences and Boston Molecules gets to work.​